Cell and gene therapy companies develop advanced treatments that modify, replace or engineer cells and genetic material to treat disease. The field is one of the fastest-growing areas of biotechnology and precision medicine.
This category includes companies working on:
Browse 163 UK cell and gene therapy companies below.
GLP/GMP biosafety testing centre of excellence for biologics and vaccines
SGS Vitrology is a biosafety testing contract research organisation operating from a 3,100m² GLP and GMP-accredited facility in Glasgow. The site serves as SGS's global centre of excellence for biosafety, providing cell bank characterisation, viral safety testing, mycoplasma detection, lot release testing, and…
University of Oxford GMP facility for clinical-grade biologics
The Clinical BioManufacturing Facility is the University of Oxford's GMP-licensed manufacturing facility, producing biological investigational medicinal products for early-phase clinical trials. The facility holds an MHRA Manufacturer's Authorisation for Investigational Medicinal Products and manufactures viral vector…
Inhaled lentiviral gene therapies for rare respiratory diseases
AlveoGene is a biotechnology company developing inhaled gene therapies for rare respiratory disorders. It uses a lentiviral vector platform engineered to deliver therapeutic genes efficiently to the cells lining the airways and lungs. Its lead programme targets alpha-1 antitrypsin deficiency, an inherited condition…